This article identifies and analyses a framework for "health baskets," the taxonomy of benefit catalogues for curative services, and the criteria for the in- or exclusion of benefits in nine EU member states (Denmark, England, France, Germany, Hungary, Italy, The Netherlands, Poland and Spain)....

Rising pharmaceutical expenditure has become a major concern for policy makers in Germany over recent years. Therefore, the pharmaceutical market has been increasingly targeted by different kinds of regulation, focussing on both the supply and the demand side, using price, volume and spending...

Over the past 20 years, most European countries have introduced DRGs or similar grouping systems as instruments for hospital reimbursement. This paper compares and analyzes the methods used to determine prices for inpatient care within DRGs or similar grouping systems employed in nine EU member...

Germany has recently introduced a system of Diagnosis Related Groups (DRGs) to engender more appropriate resource allocation. The following article describes the German DRG-system and the methodologies used to determine prices. It analyses the extent to which prices, or calculated cost weights,...

OBJECTIVES: The purpose of this study is to assess the cost-effectiveness (net costs per life year gained) of telemedical devices for pre-clinical traffic accident emergency rescue in Germany. METHODS: Two equipment versions of a telemedical device are compared from a societal perspective with...

OBJECTIVE: To calculate per-case hospital costs for patients with cystic fibrosis under routine conditions from a healthcare provider's perspective; identify the impact of different cost categories; investigate whether cases with cystic fibrosis can be grouped into homogenous cost groups...

OBJECTIVE: To examine the price reactions of German pharmacies to changes made to OTC drug regulations in 2004. Prior to these changes, regulations guaranteed identical prices in all German pharmacies. METHODS: Two years after market deregulation, 256 pharmacies were surveyed to determine the...

Different reimbursement schemes for health care providers have been developed worldwide. They have evolved over time and have been influenced by politics, costs, patient needs and technological progress. Different methods in the valuation of technologies and their reflection in outpatient...

Dieser Bericht untersucht die Folgen der COVID-19-Pandemie auf das Leistungsgeschehen der Krankenhäuser in Deutschland. Er untersucht außerdem, ob die im Jahr 2021 geleisteten Ausgleichszahlungen die Erlösminderungen der Krankenhäuser aufgrund des Rückgangs der Leistungsmenge ausgleichen...

Dieser Bericht untersucht die Folgen der Covid-19-Pandemie auf das Leistungsgeschehen der Krankenhäuser in Deutschland für den Zeitraum vom 01. Januar 2020 bis zum 31.Mai 2021. Er untersucht außerdem, ob die seit dem 16. März 2020 geltenden Ausgleichszahlungen die Erlösminderungen der...